Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Invesco Ltd. reported a 5.50% stake in Collegium Pharmaceutical, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 7, 2025
Invesco Ltd. reported a 5.50% stake in Collegium Pharmaceutical, Inc., 1,775,760 shares, as a passive investor on Dec 31, 2024. Filed Feb 7, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 1,775,760
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invesco Ltd. | 5.50% | 1,775,760 |
Source
Related
- Collegium Pharmaceutical, Inc.
- Invesco Ltd.
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G · Invesco Ltd. · May 8, 2026
- Schedule 13G/A · Invesco Ltd. · Aug 7, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026